Researchers examined data on 88 HIV patients hospitalized with COVID-19 at New York City-based Mount Sinai Health System between March 12 and April 23.
They found no significant difference in adverse outcomes between patients with HIV and other COVID-19 patients when matching for age, sex or race/ethnicity.
Eighteen percent of patients with HIV required mechanical ventilation, and 21 percent died, compared to 23 percent and 20 percent of demographically similar COVID-19 patients, respectively.
There was also no difference in COVID-19 severity upon hospital admission between the two patient groups.
To view the full study, click here.
More articles on patient safety & outcomes:
10% drop in ER volume significantly cuts patient death rates, study finds
Obesity common among kids hospitalized with COVID-19, study finds
76% of COVID-19 patients treated with convalescent plasma improve, small study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
